Ingersoll Rand Expands Life Sciences Capabilities with Acquisition of Scinomix, Inc.

Davidson, North Carolina, January 5, 2026 (Global News Wire) - Ingersoll Rand Company (NYSE: IR), a global enterprise providing critical mission flow creation as well as life science and industrial solutions, has acquired Synimox Corporation, thereby expanding its life science business portfolio.
Synimox Corporation is headquartered in the United States. The company designs and manufactures various technologies aimed at simplifying automated workflow processes, thereby enhancing production efficiency, accuracy, and traceability in multiple industries, including clinical, pharmaceutical, biotechnology, forensic, agriculture, and genetic testing laboratories. The company focuses on labeling, processing, barcode scanning, and sealing of laboratory equipment such as test tubes, vials, microplates, and liquids.
These innovative solutions are designed to improve sample management through scalable and easily configurable solutions, thereby enhancing efficiency and accuracy in various workflows. This acquisition will enable Ingersoll Rand to combine its existing technologies with Synimox's products, thereby providing a comprehensive end-to-end solution in the laboratory environment. Synimox will join the "Life Sciences" platform of the Precision and Science Technology (P&ST) department.
Ingersoll Rand Company's Chairman and Chief Executive Officer, Vincenzo Renale, stated: "We are expanding the scope of our innovative solution business and opening up new opportunities through the acquisition of Synimox Corporation. Their expertise in automation technology in the life sciences sector complements our existing capabilities, enabling us to better serve our customers. We look forward to the Synimox team joining the Ingersoll Rand family."
About Ingersoll Rand Company
Ingersoll Rand Company (NYSE: IR) is committed to creating a better life for its employees, customers, shareholders, and the planet through entrepreneurship and ownership principles. Customers trust us because we provide outstanding performance and durability in critical mission fluid manufacturing as well as life science and industrial solutions. With the support of over 80 renowned brands, our products and services perform exceptionally in the most complex and harsh environments. Our employees achieve long-term support for customers through their daily pursuit of expertise, productivity, and efficiency. For more information, please visit IRCO.com.
Forward-looking Statements
This press release contains "forward-looking statements", which are defined under the 1995 Private Securities Litigation Reform Act, including statements related to the expectations of Ingersoll Rand Company ("the Company" or "Ingersoll Rand"), involving its business performance, financial results, liquidity, and capital resources, as well as other non-historical statements. These forward-looking statements are typically identified by phrases such as "believe", "expect", "anticipate", "intend", "estimate", "predict", "project", "target", "strive", "seek", "plan", "likely result", "guidance", or similar terms (typically used to identify forward-looking statements). All statements other than historical facts are forward-looking statements.
These forward-looking statements are based on the current expectations of Ingersoll Rand Company, but are subject to risks and uncertainties that may affect actual results and may cause actual results to differ significantly from those expressed or anticipated by these forward-looking statements. If any of the above risks or uncertainties materialize, or if the underlying assumptions are incorrect, actual results may differ significantly from these forward-looking statements. The inclusion of such statements should not be construed as a guarantee that these plans, estimates or expectations will be realized. Important factors that may lead to significant differences between actual results and these plans, estimates or expectations include, but are not limited to: (1) adverse impacts on our operations and financial performance due to geopolitical tensions, natural disasters, disasters, cyber incidents or other events beyond our control; (2) unexpected costs, expenses or expenditures resulting from the completion and proposed business combinations; (3) the uncertainty of the company's expected financial performance; (4) the failure to achieve the expected benefits from the completion and proposed business combinations; (5) the company's ability to implement its business strategy; (6) difficulties and delays in the process of achieving revenue and cost synergies; (7) the inability of the company to retain and recruit key personnel; (8) changing laws, regulations and tax systems; (9) changes in the overall economic situation and/or specific industry conditions; (10) the behavior of third parties, including the behavior of government agencies; and (11) other risk factors detailed by Ingersoll Rand in its latest annual 10-K report submitted to the U.S. Securities and Exchange Commission ("SEC"), which may be updated in the company's periodic filings with the SEC, and the relevant documents can be obtained on the S website.